Asa station, Sweden

Axel K Aberg

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Hassle. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Axel K Aberg. Retrieved from https://idiyas.com/inventor/axel-k-aberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Axel K Aberg

Introduction

Axel K Aberg is a notable inventor based in Asa station, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. His innovative work has led to the development of a unique compound that showcases his expertise in medicinal chemistry.

Latest Patents

Aberg holds a patent for "Amide substituted phenoxy propanol amines." This patent describes an amine of a specific formula and outlines a method for its preparation. The compound is designed to treat cardiovascular diseases by exerting its alpha-receptor blocking activity. This innovation highlights Aberg's commitment to advancing medical treatments.

Career Highlights

Axel K Aberg is associated with Aktiebolaget Hassle, a company known for its focus on pharmaceutical development. His work at the company has allowed him to explore various avenues in drug formulation and therapeutic applications. Aberg's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Aberg has collaborated with esteemed colleagues such as Enar I Carlsson and Gustav B Samuelsson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Axel K Aberg's contributions to the field of pharmaceuticals, particularly through his patent on amide substituted phenoxy propanol amines, demonstrate his significant impact on medical science. His work continues to inspire advancements in the treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…